SOURCE: CEOLIVE.TV

May 25, 2016 10:59 ET

CEOLIVE.TV Announces New Interview With Gregory Cash, CEO of BioSig Technologies, Inc.

ORLANDO, FL--(Marketwired - May 25, 2016) - CEOLIVE, Inc., a provider of in-depth video interviews with public company CEOs (www.ceolive.tv), announced today that a new interview with Gregory Cash, CEO of BioSig Technologies, Inc. (OTCQB: BSGM), a Minnesota-based medical device company developing a proprietary technology platform designed to improve the rapidly growing multi-billion dollar electrophysiology (EP) marketplace, is now available on their website.

The video interview can be viewed at the following link:

http://ceolive.tv/bsgm-disruptive-technology-in-rapidly-growing-4b-ep-market

About BioSig Technologies

BioSig Technologies is a medical device company that is developing a proprietary technology platform designed to improve the $4 billion EP marketplace (1) (www.biosigtech.com). Led by a proven management team and a veteran, independent Board of Directors, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. To find out more about them please visit their website at www.biosigtech.com.

Disclaimer

CEOLIVE content and productions are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in CEOLIVE content and productions, or other investor relations materials and presentations are subject to change. Neither CEOLIVE nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. CEOLIVE is not a registered broker-dealer or registered investment advisor. We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov or other applicable regulatory authorities.